Cardiac 18F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA
Movement Disorders Clinical Practice, 2021•Wiley Online Library
Background Parkinson's disease with orthostatic hypotension (PD+ OH) can be difficult to
distinguish clinically from the parkinsonian form of multiple system atrophy (MSA‐P).
Previous studies examined cardiac sympathetic neuroimaging to differentiate PD from MSA
but without focusing specifically on PD+ OH versus MSA‐P, which often is the relevant
differential diagnostic issue. Objective To investigate the utility of cardiac sympathetic
neuroimaging by 18F‐dopamine positron emission tomographic (PET) scanning for …
distinguish clinically from the parkinsonian form of multiple system atrophy (MSA‐P).
Previous studies examined cardiac sympathetic neuroimaging to differentiate PD from MSA
but without focusing specifically on PD+ OH versus MSA‐P, which often is the relevant
differential diagnostic issue. Objective To investigate the utility of cardiac sympathetic
neuroimaging by 18F‐dopamine positron emission tomographic (PET) scanning for …
Background
Parkinson's disease with orthostatic hypotension (PD + OH) can be difficult to distinguish clinically from the parkinsonian form of multiple system atrophy (MSA‐P). Previous studies examined cardiac sympathetic neuroimaging to differentiate PD from MSA but without focusing specifically on PD + OH versus MSA‐P, which often is the relevant differential diagnostic issue.
Objective
To investigate the utility of cardiac sympathetic neuroimaging by 18F‐dopamine positron emission tomographic (PET) scanning for separating PD + OH from MSA‐P.
Methods
Cardiac 18F‐dopamine PET data were analyzed from 50 PD + OH and 68 MSA‐P patients evaluated at the NIH Clinical Center from 1990 to 2020. Noradrenergic deficiency was defined by interventricular septal 18F‐dopamine‐derived radioactivity <6000 nCi‐kg/cc‐mCi in the 5′ frame with mid‐point 8′ after initiation of 3′ tracer injection.
Results
18F‐Dopamine PET separated the PD + OH from the MSA‐P group with a sensitivity of 92% and specificity of 96%.
Conclusion
Cardiac 18F‐dopamine PET scanning efficiently distinguishes PD + OH from MSA‐P.
Wiley Online Library